Lyophilized Injectable Drugs Market

Lyophilized Injectable Drugs Market (Type of Packaging -Single-use Vials, Point-of-care Reconstitution, Specialty Packaging; Type of Delivery - Prefilled Diluent Syringes, Proprietary Reconstitution Devices, Single-step Devices, Multi-step Devices; Indication - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions; End user - Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

  • Rep Id : TMRGL37799
  • Published On : Feb 2019
  • No. of Pages : 179
  • Category : Pharmaceutical

1. Preface 
       1.1. Report Scope and Market Segmentation 
       1.2. Research Highlights

2. Assumptions and Research Methodology 
       2.1. Assumptions and Acronyms Used
       2.2. Research Methodology

3. Executive Summary
       3.1. Global Lyophilized Injectable Drugs Market Size (US$ Mn) and Distribution, by Region, 2018 and 2026
       3.2. Global Lyophilized Injectable Drugs Market: Market Snapshot

4. Market Overview
       4.1. Global Lyophilized Injectable Drugs Market: Type of Packaging Overview 
       4.2. Global Lyophilized Injectable Drugs Market: Key Industry Developments
       4.3. Market Dynamics
       4.4. Drivers and Restraints Snapshot Analysis
       4.5. Drivers
       4.6. Restraints
       4.7. Opportunities
       4.8. Global Lyophilized Injectable Drugs Market Revenue Projections (US$ Mn), 2016–2026

5. Key Insights
       5.1. Key Merger and Acquisitions
       5.2. Regulatory Scenario, by Country/Region

6. Global Lyophilized Injectable Drugs Market Analysis, by Type of Packaging
       6.1. Introduction
       6.2. Global Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging 
               6.2.1. Single-use Vials 
               6.2.2. Point-of-Care Reconstitution
               6.2.3. Specialty Packaging
               6.2.4. Others
       6.3. Global Lyophilized Injectable Drugs Market Analysis, by Type of Packaging 
       6.4. Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by Type of Packaging 

7. Global Lyophilized Injectable Drugs Market Analysis, by Type of Delivery
       7.1. Introduction
       7.2. Global Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery 
               7.2.1. Prefilled Diluent Syringes
               7.2.2. Proprietary Reconstitution Devices
               7.2.3. Single-step Devices 
               7.2.4. Multi-step Devices
       7.3. Global Lyophilized Injectable Drugs Market Analysis, by Type of Delivery 
       7.4. Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by Type of Delivery

8. Global Lyophilized Injectable Drugs Market Analysis, by Indication 
       8.1. Introduction
       8.2. Global Lyophilized Injectable Drugs Market Size and Forecast, by Indication
               8.2.1. Autoimmune Diseases
               8.2.2. Infectious Diseases
               8.2.3. Metabolic Conditions
               8.2.4. Others
       8.3. Global Lyophilized Injectable Drugs Market Analysis, by Indication
       8.4. Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by Indication

9. Global Lyophilized Injectable Drugs Market Analysis, by End-user
       9.1. Introduction
       9.2. Global Lyophilized Injectable Drugs Market Size and Forecast, by End-user
               9.2.1. Hospitals
               9.2.2. Ambulatory Surgical Centers
               9.2.3. Specialty Clinics
               9.2.4. Others
       9.3. Global Lyophilized Injectable Drugs Market Analysis, by End-user
       9.4. Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by End-user

10. Global Lyophilized Injectable Drugs Market Analysis, by Region
       10.1. Global Lyophilized Injectable Drugs Market Size and Forecast, by Region, 2016–2026 
               10.1.1. North America
               10.1.2. Europe
               10.1.3. Asia Pacific
               10.1.4. Latin America
               10.1.5. Middle East & Africa
       10.2. Global Lyophilized Injectable Drugs Market Analysis, by Region
       10.3. Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by Region

11. North America Lyophilized Injectable Drugs Market Analysis
       11.1. North America Lyophilized Injectable Drugs Market 
       11.2. North America Lyophilized Injectable Drugs Market Overview
       11.3. North America Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging 
               11.3.1. Single-use Vials 
               11.3.2. Point-of-Care Reconstitution
               11.3.3. Specialty Packaging
               11.3.4. Others
       11.4. North America Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
               11.4.1. Prefilled Diluent Syringes
               11.4.2. Proprietary Reconstitution Devices
               11.4.3. Single-step Devices 
               11.4.4. Multi-step Devices 
       11.5. North America Lyophilized Injectable Drugs Market Size and Forecast, by Indication
               11.5.1. Autoimmune Diseases
               11.5.2. Infectious Diseases
               11.5.3. Metabolic Conditions
               11.5.4. Others
       11.6. North America Lyophilized Injectable Drugs Market Size and Forecast, by End-user 
               11.6.1. Hospitals
               11.6.2. Ambulatory Surgical Centers
               11.6.3. Specialty Clinics
               11.6.4. Others
       11.7. North America Lyophilized Injectable Drugs Market Forecast, by Country
               11.7.1. U.S.
               11.7.2. Canada
       11.8. North America Lyophilized Injectable Drugs Market Attractiveness Analysis 
               11.8.1. By Type of Packaging
               11.8.2. By Type of Delivery
               11.8.3. By Indication
               11.8.4. By End-user
               11.8.5. By Country

12. Europe Lyophilized Injectable Drugs Market Analysis
       12.1. Europe Lyophilized Injectable Drugs Market 
       12.2. Europe Lyophilized Injectable Drugs Market Overview
       12.3. Europe Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging 
               12.3.1. Single-use Vials 
               12.3.2. Point-of-Care Reconstitution
               12.3.3. Specialty Packaging
               12.3.4. Others
       12.4. Europe Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
               12.4.1. Prefilled Diluent Syringes
               12.4.2. Proprietary Reconstitution Devices
               12.4.3. Single-step Devices 
               12.4.4. Multi-step Devices 
       12.5. Europe Lyophilized Injectable Drugs Market Size and Forecast, by Indication
               12.5.1. Autoimmune Diseases
               12.5.2. Infectious Diseases
               12.5.3. Metabolic Conditions
               12.5.4. Others
       12.6. Europe Lyophilized Injectable Drugs Market Size and Forecast, by End-user 
               12.6.1. Hospitals
               12.6.2. Ambulatory Surgical Centers
               12.6.3. Specialty Clinics
               12.6.4. Others
       12.7. Europe Lyophilized Injectable Drugs Market Forecast, by Country/Sub-region
               12.7.1. U.K.
               12.7.2. France
               12.7.3. Germany
               12.7.4. Spain
               12.7.5. Italy
               12.7.6. Rest of Europe
       12.8. Europe Lyophilized Injectable Drugs Market Attractiveness Analysis 
               12.8.1. By Type of Packaging
               12.8.2. By Type of Delivery
               12.8.3. By Indication
               12.8.4. By End-user
               12.8.5. By Country/Sub-region

13. Asia Pacific Lyophilized Injectable Drugs Market Analysis
       13.1. Asia Pacific Lyophilized Injectable Drugs Market Key Findings
       13.2. Asia Pacific Lyophilized Injectable Drugs Market Overview
       13.3. Asia Pacific Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging 
               13.3.1. Single-use Vials 
               13.3.2. Point-of-Care Reconstitution
               13.3.3. Specialty Packaging
               13.3.4. Others
       13.4. Asia Pacific Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
               13.4.1. Prefilled Diluent Syringes
               13.4.2. Proprietary Reconstitution Devices
               13.4.3. Single-step Devices 
               13.4.4. Multi-step Devices 
       13.5. Asia Pacific Lyophilized Injectable Drugs Market Size and Forecast, by Indication
               13.5.1. Autoimmune Diseases
               13.5.2. Infectious Diseases
               13.5.3. Metabolic Conditions
               13.5.4. Others
       13.6. Asia Pacific Lyophilized Injectable Drugs Market Size and Forecast, by End-user 
               13.6.1. Hospitals
               13.6.2. Ambulatory Surgical Centers
               13.6.3. Specialty Clinics
               13.6.4. Others
       13.7. Asia Pacific Lyophilized Injectable Drugs Market Forecast, by Country/Sub-region
               13.7.1. China
               13.7.2. India
               13.7.3. Japan
               13.7.4. Australia & New Zealand
               13.7.5. Rest of Asia Pacific
       13.8. Asia Pacific Lyophilized Injectable Drugs Market Attractiveness Analysis 
               13.8.1. By Type of Packaging
               13.8.2. By Type of Delivery
               13.8.3. By Indication
               13.8.4. By End-user
               13.8.5. By Country/Sub-region

14. Latin America Lyophilized Injectable Drugs Market Analysis
       14.1. Latin America Lyophilized Injectable Drugs Market Key Findings
       14.2. Latin America Lyophilized Injectable Drugs Market Overview
       14.3. Latin America Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging 
               14.3.1. Single-use Vials 
               14.3.2. Point-of-Care Reconstitution
               14.3.3. Specialty Packaging
               14.3.4. Others
       14.4. Latin America Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
               14.4.1. Prefilled Diluent Syringes
               14.4.2. Proprietary Reconstitution Devices
               14.4.3. Single-step Devices 
               14.4.4. Multi-step Devices 
       14.5. Latin America Lyophilized Injectable Drugs Market Size and Forecast, by Indication
               14.5.1. Autoimmune Diseases
               14.5.2. Infectious Diseases
               14.5.3. Metabolic Conditions
               14.5.4. Others
       14.6. Latin America Lyophilized Injectable Drugs Market Size and Forecast, by End-user 
               14.6.1. Hospitals
               14.6.2. Ambulatory Surgical Centers
               14.6.3. Specialty Clinics
               14.6.4. Others
       14.7. Latin America Lyophilized Injectable Drugs Market Forecast, by Country/Sub-region
               14.7.1. Brazil 
               14.7.2. Mexico
               14.7.3. Rest of Latin America
       14.8. Latin America Lyophilized Injectable Drugs Market Attractiveness Analysis 
               14.8.1. By Type of Packaging
               14.8.2. By Type of Delivery
               14.8.3. By Indication
               14.8.4. By End-user
               14.8.5. By Country/Sub-region

15. Middle East & Africa Lyophilized Injectable Drugs Market Analysis
       15.1. Middle East & Africa Lyophilized Injectable Drugs Market 
       15.2. Middle East & Africa Lyophilized Injectable Drugs Market Size and Forecast, by Type of Packaging 
               15.2.1. Single-use Vials 
               15.2.2. Point-of-Care Reconstitution
               15.2.3. Specialty Packaging
               15.2.4. Others
       15.3. Middle East & Africa Lyophilized Injectable Drugs Market Size and Forecast, by Type of Delivery
               15.3.1. Prefilled Diluent Syringes
               15.3.2. Proprietary Reconstitution Devices
               15.3.3. Single-step Devices 
               15.3.4. Multi-step Devices 
       15.4. Middle East & Africa Lyophilized Injectable Drugs Market Size and Forecast, by Indication
               15.4.1. Autoimmune Diseases
               15.4.2. Infectious Diseases
               15.4.3. Metabolic Conditions
               15.4.4. Others
       15.5. Middle East & Africa Lyophilized Injectable Drugs Market Size and Forecast, by End-user 
               15.5.1. Hospitals
               15.5.2. Ambulatory Surgical Centers
               15.5.3. Specialty Clinics
               15.5.4. Others
       15.6. Middle East & Africa Lyophilized Injectable Drugs Market Forecast, by Country/Sub-region
               15.6.1. GCC Countries
               15.6.2. South Africa
               15.6.3. Rest of Middle East & Africa
       15.7. Middle East & Africa Lyophilized Injectable Drugs Market Attractiveness Analysis 
               15.7.1. By Type of Packaging
               15.7.2. By Type of Delivery
               15.7.3. By Indication
               15.7.4. By End-user
               15.7.5. By Country/Sub-region

16. Competition Landscape
       16.1. Company Profiles
               16.1.1. B. Braun Melsungen AG
                             16.1.1.1. Overview (HQ, Employee Strength, Business Segments)
                             16.1.1.2. Financials
                             16.1.1.3. Recent Developments
                             16.1.1.4. Strategy
               16.1.2. Baxter
                             16.1.2.1. Overview (HQ, Employee Strength, Business Segments)
                             16.1.2.2. Financials
                             16.1.2.3. Recent Developments
                             16.1.2.4. Strategy
               16.1.3. Becton, Dickinson and Company 
                             16.1.3.1. Overview (HQ, Employee Strength, Business Segments)
                             16.1.3.2. Financials
                             16.1.3.3. Recent Developments
                             16.1.3.4. Strategy
               16.1.4. Mylan N.V.
                             16.1.4.1. Overview (HQ, Employee Strength, Business Segments)
                             16.1.4.2. Financials
                             16.1.4.3. Recent Developments
                             16.1.4.4. Strategy
               16.1.5. Schott AG 
                             16.1.5.1. Overview (HQ, Employee Strength, Business Segments)
                             16.1.5.2. Financials
                             16.1.5.3. Recent Developments
                             16.1.5.4. Strategy
               16.1.6. SHL Group
                             16.1.6.1. Overview (HQ, Employee Strength, Business Segments)
                             16.1.6.2. Financials
                             16.1.6.3. Recent Developments
                             16.1.6.4. Strategy
               16.1.7. Vetter Pharma 
                             16.1.7.1. Overview (HQ, Employee Strength, Business Segments)
                             16.1.7.2. Financials
                             16.1.7.3. Recent Developments
                             16.1.7.4. Strategy
               16.1.8.  CIRON Drugs & Pharmaceuticals Pvt. Ltd.
                             16.1.8.1. Overview (HQ, Employee Strength, Business Segments)
                             16.1.8.2. Financials
                             16.1.8.3. Recent Developments
                             16.1.8.4. Strategy
               16.1.9. Jubilant HollisterStier 
                             16.1.9.1. Overview (HQ, Employee Strength, Business Segments)
                             16.1.9.2. Financials
                             16.1.9.3. Recent Developments
                             16.1.9.4. Strategy       

 

List of Tables

TABLE 1 Global Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 2 Global Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 3 Global Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 4 Global Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026
TABLE 5 Global Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Region, 2016–2026
TABLE 6 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Country, 2016–2026
TABLE 7 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 8 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 9 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 10 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026
TABLE 11 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 12 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 13 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 14 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 15 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026
TABLE 16 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 17 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 18 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 19 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 20 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026
TABLE 21 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 22 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 23 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 24 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 25 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026
TABLE 26 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 27 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Packaging, 2016–2026
TABLE 28 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Type of Delivery, 2016–2026
TABLE 29 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by Indication, 2016–2026
TABLE 30 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast, by End-user, 2016–2026

List of Figures

FIG. 1 Global Lyophilized Injectable Drugs Market Size (US$ Mn) Forecast, 2018–2026
FIG. 2 Global Lyophilized Injectable Drugs Market Value Share, by Type of Packaging, 2017
FIG. 3 Global Lyophilized Injectable Drugs Market Value Share, Indication, 2017
FIG. 4 Global Lyophilized Injectable Drugs Market Value Share, by Type of Delivery, 2017
FIG. 5 Global Lyophilized Injectable Drugs Market Value Share, End-user, 2017
FIG. 6  Global Lyophilized Injectable Drugs Market Value Share (%), by Type of Packaging, 2017 and 2026
FIG. 7 Global Lyophilized Injectable Drugs Market Attractiveness, by Type of Packaging, 2018–2026
FIG. 8 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Single-use Vials, 2016–2026
FIG. 9 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Point-of-care Reconstitution, 2016–2026
FIG. 10 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Specialty Packaging, 2016–2026
FIG. 11 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2016–2026
FIG. 12  Global Lyophilized Injectable Drugs Market Value Share (%), by Type of Delivery, 2017 and 2026
FIG. 13 Global Lyophilized Injectable Drugs Market Attractiveness, by Type of Delivery, 2018–2026
FIG. 14 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Prefilled Diluent Syringes, 2016–2026
FIG. 15 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Proprietary Reconstitution Devices, 2016–2026
FIG. 16 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Single-step Devices, 2016–2026
FIG. 17 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Multi-step Devices, 2016–2026
FIG. 18 Global Lyophilized Injectable Drugs Market Value Share (%), by Indication, 2017 and 2026
FIG. 19 Global Lyophilized Injectable Drugs Market Attractiveness, by Indication, 2018–2026
FIG. 20 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Autoimmune Diseases, 2016–2026
FIG. 21 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Infectious Diseases, 2016–2026
FIG. 22 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Metabolic Conditions, 2016–2026
FIG. 23 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2016–2026
FIG. 24 Global Lyophilized Injectable Drugs Market Value Share Analysis, by End-user, 2017 and 2026
FIG. 25 Global Lyophilized Injectable Drugs Market Attractiveness, by End-user, 2018–2026
FIG. 26 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2016–2026
FIG. 27 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Ambulatory Surgical Centers, 2016–2026
FIG. 28 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Specialty Clinics, 2016–2026
FIG. 29 Global Lyophilized Injectable Drugs Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2016–2026
FIG. 30 Global Lyophilized Injectable Drugs Market Value Share Analysis, by Region, 2016 and 2025
FIG. 31 Global Lyophilized Injectable Drugs Market Attractiveness Analysis, by Region, 2018–2026
FIG. 32 North America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
FIG. 33 North America Lyophilized Injectable Drugs Market Value Share, by Country, 2017 and 2026
FIG. 34 North America Lyophilized Injectable Drugs Market Attractiveness, by Country, 2018–2026
FIG. 35 North America Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Packaging, 2017 and 2026
FIG. 36 North America Lyophilized Injectable Drugs Market Attractiveness, by Type of Packaging, 2018–2026
FIG. 37 North America Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Delivery, 2017 and 2026
FIG. 38 North America Lyophilized Injectable Drugs Market Attractiveness, by Type of Delivery, 2018–2026
FIG. 39 North America Lyophilized Injectable Drugs Market Value Share Analysis, by Indication, 2017 and 2026
FIG. 40 North America Lyophilized Injectable Drugs Market Attractiveness, by Indication, 2018–2026
FIG. 41 North America Lyophilized Injectable Drugs Market Value Share Analysis, by End-user, 2017 and 2026
FIG. 42 North America Lyophilized Injectable Drugs Market Attractiveness, by End-user, 2018–2026
FIG. 43 Europe Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
FIG. 44 Europe Lyophilized Injectable Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
FIG. 45 Europe Lyophilized Injectable Drugs Market Attractiveness, by Country/Sub-region, 2018–2026
FIG. 46 Europe Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Packaging, 2017 and 2026
FIG. 47 Europe Lyophilized Injectable Drugs Market Attractiveness, by Type of Packaging, 2018–2026
FIG. 48 Europe Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Delivery, 2017 and 2026
FIG. 49 Europe Lyophilized Injectable Drugs Market Attractiveness, by Type of Delivery, 2018–2026
FIG. 50 Europe Lyophilized Injectable Drugs Market Value Share Analysis, by Indication, 2017 and 2026
FIG. 51 Europe Lyophilized Injectable Drugs Market Attractiveness, by Indication, 2018–2026
FIG. 52 Europe Lyophilized Injectable Drugs Market Value Share Analysis, by End-user, 2017 and 2026
FIG. 53 Europe Lyophilized Injectable Drugs Market Attractiveness, by End-user, 2018–2026
FIG. 54 Asia Pacific Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
FIG. 55 Asia Pacific Lyophilized Injectable Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
FIG. 56 Asia Pacific Lyophilized Injectable Drugs Market Attractiveness, by Country/Sub-region, 2018–2026
FIG. 57 Asia Pacific Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Packaging, 2017 and 2026
FIG. 58 Asia Pacific Lyophilized Injectable Drugs Market Attractiveness, by Type of Packaging, 2018–2026
FIG. 59 Asia Pacific Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Delivery, 2017 and 2026
FIG. 60 Asia Pacific Lyophilized Injectable Drugs Market Attractiveness, by Type of Delivery, 2018–2026
FIG. 61 Asia Pacific Lyophilized Injectable Drugs Market Value Share Analysis, by Indication, 2017 and 2026
FIG. 62 Asia Pacific Lyophilized Injectable Drugs Market Attractiveness, by Indication, 2018–2026
FIG. 63 Asia Pacific Lyophilized Injectable Drugs Market Value Share Analysis, by End-user, 2017 and 2026 
FIG. 64 Asia Pacific Lyophilized Injectable Drugs Market Attractiveness, by End-user, 2018–2026
FIG. 65 Latin America Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
FIG. 66 Latin America Lyophilized Injectable Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
FIG. 67 Latin America Lyophilized Injectable Drugs Market Attractiveness, by Country/Sub-region, 2018–2026
FIG. 68 Latin America Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Packaging, 2017 and 2026
FIG. 69 Latin America Lyophilized Injectable Drugs Market Attractiveness, by Type of Packaging, 2018–2026
FIG. 70 Latin America Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Delivery, 2017 and 2026
FIG. 71 Latin America Lyophilized Injectable Drugs Market Attractiveness, by Type of Delivery, 2018–2026
FIG. 72 Latin America Lyophilized Injectable Drugs Market Value Share Analysis, by Indication, 2017 and 2026
FIG. 73 Latin America Lyophilized Injectable Drugs Market Attractiveness, by Indication, 2018–2026
FIG. 74 Latin America Lyophilized Injectable Drugs Market Value Share Analysis, by End-user, 2017 and 2026
FIG. 75 Latin America Lyophilized Injectable Drugs Market Attractiveness, by End-user, 2018–2026
FIG. 76 Middle East & Africa Lyophilized Injectable Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
FIG. 77 Middle East & Africa Lyophilized Injectable Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
FIG. 78 Middle East & Africa Lyophilized Injectable Drugs Market Attractiveness, by Country/Sub-region, 2018–2026
FIG. 79 Middle East & Africa Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Packaging, 2017 and 2026
FIG. 80 Middle East & Africa Lyophilized Injectable Drugs Market Attractiveness, by Type of Packaging, 2018–2026
FIG. 81 Middle East & Africa Lyophilized Injectable Drugs Market Value Share Analysis, by Type of Delivery, 2017 and 2026
FIG. 82 Middle East & Africa Lyophilized Injectable Drugs Market Attractiveness, by Type of Delivery, 2018–2026
FIG. 83 Middle East & Africa Lyophilized Injectable Drugs Market Value Share Analysis, by Indication, 2017 and 2026
FIG. 84 Middle East & Africa Lyophilized Injectable Drugs Market Attractiveness, by Indication, 2018–2026
FIG. 85 Middle East & Africa Lyophilized Injectable Drugs Market Value Share Analysis, by End-user, 2017 and 2026
FIG. 86 Middle East & Africa Lyophilized Injectable Drugs Market Attractiveness, by End-user, 2018–2026

 

.